Abstract
The role of subtypes of lymphocytes in the progression of coronary heart disease may be a new strategic target in the therapy of myocardial infarction. The muscle loss following the coronary occlusion adds prognostic information and early reperfusion constitutes the key strategy for these patients. However, surrounding the necrotic core, an ischemic area is formed, that progresses to exte…